Vascular endothelial growth factor/vascular permeability factor in the pathogenesis of primary effusion lymphomas

Leukemia and Lymphoma

Volumn 41, Issue 3-4, 2001, Pages 229-237

  Aoki, Y ^a   Tosato, G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

AIDS; Flt 1; KDR Flk 1; KSHV HHV 8; PEL; VEGF VPF

Indexed keywords

FETAL LIVER TYROSINE KINASE 1 RECEPTOR; FMS LIKE TYROSINE KINASE 1 RECEPTOR; ISOPROTEIN; RNA; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ASCITES; BLOOD VESSEL PERMEABILITY; CANCER CELL CULTURE; CELL MEMBRANE; CELL PROLIFERATION; CELL SECRETION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; LYMPHATIC SYSTEM TUMOR; LYMPHOMA; MOUSE; NONHUMAN; PATHOGENESIS; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA ANALYSIS; SCID MOUSE;

EID: 0034988689     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109057978     Document Type: Review

References (39)

1. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis
2. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody
3. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus
4. Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphomas
5. Acquired immunodeficiency syndrome-related lymphoma
6. HIV infection and neoplasia
7. Genetic basis of acquired immunodeficiency syndrome-related lymphomagenesis
8. Primary body cavity-basedAIDS-related lymphomas
9. Immunodeficiency-associated lymphoproliferative disorders
10. Primary effusion lymphoma: A distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus
11. Establishing a KSHV + cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice
12. Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen
13. Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas
14. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS- related body-cavity-based lymphomas
15. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8)
16. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6
17. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6
18. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease
19. Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells
20. Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions
21. Vascular endothelial growth factor: Molecular and biological aspects
22. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin
23. Angiogenesis in cancer, vascular, rheumatoid and other disease
24. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
25. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
26. Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells
27. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
28. Role of VEGF-flt receptor system in normal and tumor angiogenesis
29. Role of vascular endothelial growth factor in ovarian cancer: Inhibition of ascites formation by immunoneutralization
30. Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors
31. Markedly elevated levels of vascular endothelial growth factor in malignant ascites
32. Detection of vascular endothelial growth factor in AIDS-related primary effusion lymphomas
33. A role for the interferon-inducible protein 10 in inhibition of angiogenesis by interleukin-12
34. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix
35. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis
36. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
37. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
38. Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: Ultrastructural demonstration of herpesvirus in lymphoma cells
39. The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions